Induced Pluripotent Stem Cells News and Research

RSS
Stanford researchers make hair-cell-like cells in a petri dish

Stanford researchers make hair-cell-like cells in a petri dish

Fragile X syndrome iPS cells and embryonic stem cells behave differently: Study

Fragile X syndrome iPS cells and embryonic stem cells behave differently: Study

CDI, iPS Academia Japan announce licensing agreement for seminal iPSC patent portfolio

CDI, iPS Academia Japan announce licensing agreement for seminal iPSC patent portfolio

iPierian receives $1.5M Basic Biology Award from CIRM to study cellular reprogramming

iPierian receives $1.5M Basic Biology Award from CIRM to study cellular reprogramming

UC Irvine scientists receive CIRM grants for stem cell research

UC Irvine scientists receive CIRM grants for stem cell research

New reprogramming strategies needed for production of iPSCs: Study

New reprogramming strategies needed for production of iPSCs: Study

CDI's iCell Cardiomyocytes named to MIT Technology Review's Annual 10 Emerging Technologies List

CDI's iCell Cardiomyocytes named to MIT Technology Review's Annual 10 Emerging Technologies List

Marker found in iPS cells correlates with levels of pluripotency: Researchers

Marker found in iPS cells correlates with levels of pluripotency: Researchers

Stem cell scientists receive stimulus grants to study lung and blood disorders

Stem cell scientists receive stimulus grants to study lung and blood disorders

Fate Therapeutics to acquire Ottawa biotechnology company Verio Therapeutics

Fate Therapeutics to acquire Ottawa biotechnology company Verio Therapeutics

Human amniotic fluid skin cells "reprogrammed" to pluripotency

Human amniotic fluid skin cells "reprogrammed" to pluripotency

Keynote speakers to discuss regenerative medicine therapies at upcoming forum

Keynote speakers to discuss regenerative medicine therapies at upcoming forum

"Stem cells in drug discovery and development" workshop to be held during toxicology annual meeting

"Stem cells in drug discovery and development" workshop to be held during toxicology annual meeting

Fate Therapeutics named to Technology Review's 2010 TR50 most innovative companies in the world list

Fate Therapeutics named to Technology Review's 2010 TR50 most innovative companies in the world list

U.S. government's decision helped stem-cell researchers concentrate on science, but limitations remain

U.S. government's decision helped stem-cell researchers concentrate on science, but limitations remain

ACT's research on therapeutic cell types obtained from iPS cells featured in leading news media outlets

ACT's research on therapeutic cell types obtained from iPS cells featured in leading news media outlets

Children's Hospital of Philadelphia awarded two grants to research into cellular therapies for blood disorders

Children's Hospital of Philadelphia awarded two grants to research into cellular therapies for blood disorders

Transition through hemogenic endothelial intermediate necessary for hematopoietic stem cell formation

Transition through hemogenic endothelial intermediate necessary for hematopoietic stem cell formation

hESC and iPSC: Long-term stem cell evaluation and comparison study

hESC and iPSC: Long-term stem cell evaluation and comparison study

Stanford researchers use DNA minicircles to induce pluripotency in stem cells from human fat

Stanford researchers use DNA minicircles to induce pluripotency in stem cells from human fat